2000

2000 GRC ON MEDICAL CHEMISTRY

• DAY:
• Place：COLBY-SAWYER COLLEGE, NEW LONDON, NH, U.S.A
• Calpain inhibitors for cataracts and retinal degeneration
• Chair: Graham Johnson BMS
  Vice-Chair: Kelvin Cooper Pfize
  r Chair: Kelvin Cooper Pfizer
  Discussion Leader: Michael Rafferty, Parke-Davis, Warner-Lambert, Jun Inoue (Senju Pharmaceuticals)

Fourth Australia / Japan joint symposium on Drug Design and Development

• DAY:
• Place：Melbourne, Australia
• Structure-activity relationship study and anti-cataract activity of N-sulfonyl-dipeptide aldehyde as a potent calpain inhibitor
• Jun Inoue, Masayuki Nakamura, Yoshiyuki Tamada, TYoshikuni Nakamura,Osamu Sakai, and Mitsuyoshi Azuma

The Association for Research in Vision and Ophthalmology (ARVO)

• DAY:
• Place：Florida, U.S.A.

● Tittle List
<< Poster >>
　・CALPAIN　　　　 M. Azuma
　 UV-B Oxidation Enhances Calpain-Induced Light Scattering in Young Rat Lenses.
　・CALPAIN 　　　　C. Fukiage
　 Tissue Specific Calpains from Rat Retina.
　・CALPAIN 　　　　T. Nakajima
　 Involvement of Calpain Isoforms in Ischemia-Reperfusion Injury in Rat Retina. 　 　 　

3rd International Symposium on Ocular Pharmacology and Pharmaceutics(ISOPP)

• DAY:
• Place：Lisbon, PORTUGAL

● NTERNATIONAL ADVISORY BOARD
＜Scientific Advisory Board in Japan＞
N. Araie （University of Tokyo） , Y. Honda （Kyoto University）, K. kitazawa （Gifu University）, S. Kinoshita （Kyoto Prefectural University of Medicine）,　K. Tsubota （Tokyo Dental College）, S. Kashii （Kyoto University）, T. Hiramitsu （Hamamatsu University School of Medicine）, H. Nishigori （Teikyo University）, A. Okumura （Senju Pharmaceutical Ltd.,）

● Tittle List
<< Sponsored Product Session >>
　・BROMFENAC 　　　　M. Isaka
　 A new cyclooxygenase inhibitor as analgestic and anti-inflammatory agent
　・GATIFLOXACIN　　　 A. Okumura
　 New 8-methoxy quinolone, gatifloxacin
　・RISARESTAT(CT-112) 　　　T. Kikuya
　 Topical aldose reductase inhibitor, risarestat(CT-112), for diabetic keratopathy

<< Oral presentation or Poster >>
　・TA-2711　　　 H. Tokushige
　 Effect of Ecabet Sodium on Secretion of Mucin-like Glycoproteins in Ocular Surface
　・DIFLUPREDNATE　　　 M. Yamaguchi
　 Studies on Intraocular Penetration of Steroid Ophthalmic Emulsion
　・BROMFENAC　　　 M. Isaka
　 Bromfenac Safety to Liver : A Case for Ophthalmic Administration
　・TIMOLOL-LA 　　　M. Higashiyama
　 Ocular Bioavailability Improved by Computer Simulation
　・SJA-6017 　　　Y. Sakamoto
　 Protection by a Calpain Inhibitor of Neuronal Cells from Ischemic Injury in Retina
　・ROCK INHIBITOR　　　　M. Waki
　 Rho-kinase Inhibitor, Y-27632, as a Possible Anti-glaucomatous Drug
　・Rt 88 　　　C. Fukiage
　 Tissue Specific Caplains in the Eye

new | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999